Jackisch C, Harbeck N, Huober J et al. 14th St Gallen International Breast Cancer Conference 2015: evidence, controversies, consensus - primary therapy of early breast cancer: opinions expressed by German Experts. Breast Care. 2015;10(211–9).

Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11(10):927–933

Article  PubMed  PubMed Central  Google Scholar 

Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-n- ode biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546–553

Article  PubMed  Google Scholar 

Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E et al (2015) Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 26(Supplement 5):v8-30

Article  PubMed  Google Scholar 

Fernandez-Gonzalez S, Falo C, Pla MJ, Pernas S, Bajen M, Soler T et al (2018) The shift from sentinel lymph node biopsy performed either before or after neoadjuvant systemic therapy in the clinical negative nodes of breast cancer patients. Results, and the advantages and disadvantages of both procedures. Clin Breast Cancer 18(1):71–77

Article  PubMed  Google Scholar 

van Rijk MC, Nieweg OE, Rutgers EJ et al (2006) Sentinel node biopsy before neoadjuvant chemotherapy spares breast cancer patients axillary lymph node dissection. Ann Surg Oncol 13(4):475–479

Article  PubMed  Google Scholar 

Grube BJ, Christy CJ, Black D et al (2008) Breast sentinel lymph node dissection before preoperative chemotherapy. Arch Surg 143(7):692–699

Article  PubMed  Google Scholar 

van Deurzen CH, Vriens BE, Tjan-Heijnen VC et al (2009) Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review. Eur J Cancer 45:3124–3130

Article  PubMed  Google Scholar 

Kelly AM, Dwamena B, Cronin PCR (2009) Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta-analysis. Acad Radiol 16:551–563

Article  PubMed  Google Scholar 

Shirzadi A, Habibollah Mahmoodzadeh MQ (2019) Assessment of sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer in two subgroups Initially node negative and node positive converted to node negative – A systemic review and meta-analysis. J Res Med Sci 25(24):18

Article  Google Scholar 

Network NCC. Breast cancer. Version 4.2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.

Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM et al (2021) Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol 32(10):1216–1235

Article  CAS  PubMed  Google Scholar 

Curigliano G, Burstein HJ, Gnant M, Loibl S, Cameron D, Regan MM, et al. Understanding breast cancer complexity to improve patient outcomes: The St. Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol. 2023; ep 6:S0923–7534(23)00835–9.

Gandhi S, Brackstone M, Hong NJL, Grenier D, Donovan E, Lu F-I et al (2022) A Canadian national guideline on the neoadjuvant treatment of invasive breast cancer, including patient assessment, systemic therapy, and local management principles. Breast Cancer Res Treat 193(1):1–20

Article  PubMed  PubMed Central  Google Scholar 

Friedrich M, Kühn T, Wolfgang Janni VM et al (2021) AGO recommendations for the surgical therapy of the axilla after neoadjuvant chemotherapy: 2021 update. Geburtshilfe Frauenheilkd 81(10):1112–1120

Article  PubMed  PubMed Central  Google Scholar 

Tsujimoto M, Nakabayashi K, Yoshidome K, Kaneko T, Iwase T, Akiyama F et al (2007) One-step nucleic acid amplification for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 13(16):4807–4816

Article  CAS  PubMed  Google Scholar 

Masuda N, Lee S-J, Ohtani S, Im Y-H, Lee E-S, Yokota I et al (2017) Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 376(22):2147–2159

Article  CAS  PubMed  Google Scholar 

Tirkes T, Hollar MA, Tann M, Kohli MD, Akisik FSK (2013) Response criteria in oncologic imaging: review of traditional and new criteria. Radiographics 33(5):1323–1341

Article  PubMed  Google Scholar 

Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T et al (2010) A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Cancer Res 16(21):5222–5232

CAS  Google Scholar 

Goldhirsch a, Winer EP, Coates a S, Gelber RD, Piccart-Gebhart M, Thürlimann B, et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24(9):2206–2223

Article  PubMed  Google Scholar 

Salinas-Huertas S, Luzardo-González A, Vázquez-Gallego S, Pernas S, Falo C, Pla MJ et al (2022) Risk factors for lymphedema after breast surgery: A prospective cohort study in the era of sentinel lymph node biopsy. Breast Dis 41(1):97–108

Article  CAS  PubMed  Google Scholar 

Bromham N, Schmidt-Hansen M, Astin M, Hasler E, Reed MW (2017) Axillary treatment for operable primary breast cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004561.pub3

Article  PubMed  PubMed Central  Google Scholar 

Vázquez JC, Piñero A, de Castro FJ, Lluch A, Martín M, Barnadas A et al (2022) The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview. Clin Transl Oncol 24(9):1744–1754

Article  PubMed  Google Scholar 

Zarifmahmoudi L, Aghaee A, Treglia G, Sadeghi R (2022) Sentinel lymph node mapping in breast cancer patients following neoadjuvant chemotherapy: systematic review and meta-analysis about head to head comparison of cN0 and cN + patients. Breast Cancer 29(1):50–64

Article  PubMed  Google Scholar 

Lin SQ, Vo NP, Yen YC, Tam KW (2022) Outcomes of Sentinel Node Biopsy for Women with Breast Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis of Real-World Data. Ann Surg Oncol 29(5):3038–3049

Article  PubMed  Google Scholar 

Geng C, Chen X, Pan X, Li J (2016) The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: A systematic review and meta-analysis. PLoS ONE 11(9):1–16

Article  Google Scholar 

Fontein DBY, Van De Water W, Mieog JSD, Liefers GJ, Van De Velde CJH (2013) Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy-Recommendations for clinical guidance. Eur J Surg Oncol 39(5):417–424

Article  PubMed  Google Scholar 

Navarro-Cecilia J, Dueñas-Rodríguez B, Luque-López C et al (2013) Intraoperative sentinel node biopsy by one-step nucleic acid amplification (OSNA) avoids axillary lymphadenectomy in women with breast cancer treated with neoadjuvant chemotherapy. Eur J Surg Oncol 39:873–879

Article  CAS  PubMed  Google Scholar 

Hunt KK, Yi M, Mittendorf EA et al (2009) Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg 250:558–566

Article  PubMed  Google Scholar 

Classe JM, Loaec C, Gimbergues P, Alran S, de Lara CT, Dupre PF et al (2019) Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study. Breast Cancer Res Treat 173(2):343–352

Article  PubMed  Google Scholar 

Wong SM, Almana N, Choi J, Hu J, Gagnon H, Natsuhara K et al (2019) Prognostic significance of residual axillary nodal micrometastases and isolated tumor cells after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol 26(11):3502–3509

Article  PubMed  Google Scholar 

Tinterri C, Canavese G, Paolo Bruzzi BD (2019) NEONOD 2: Rationale and design of a multicenter non-inferiority trial to assess the effect of axillary surgery omission on the outcome of breast cancer patients presenting only micrometastasis in the sentinel lymph node after neoadjuvant chemotherapy. Contemp Clin Trials Commun. 17:100496

Article  PubMed  PubMed Central  Google Scholar 

V. Galimberti, B.F. Cole, G. Viale, P. Veronesi, E. Vicini, M. Intra GM, Massaru et al. International Breast Cancer Study Group Trial 23–01. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinelnode micrometastases (IBCSG 23–01): 10-year follow-up of a randomised, controlled phase 3 trial,. Lancet Oncol 1. 9((10)):1385–1393,.

Galimberti V, Cole BF, Zurrida S, Viale G, Luini A, Veronesi P et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel node micrometastasis (IBCSG 23–01): a phase 3 randomised controlled trial. Lancet Oncol 14:297–305

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Tejedor A, Ortega-Exposito C, Salinas S, Luzardo-González A, Falo C, Martinez-Pérez E, Héctor Pérez-Montero M, Soler-Monsó T, Bajen M-T, Benitez A, Ortega R, Petit A, Guma A, Campos M, Maria ML (2023) Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial). Front Oncol. https://doi.org/10.3389/fonc.2023.1184021

Article  PubMed  PubMed Central  Google Scholar